Difference between revisions of "Non-pegylated liposomal doxorubicin (Myocet)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) (Created page with "==General information== Class/mechanism: A formulation of the citrate salt of the antineoplastic anthracycline antibiotic doxorubicin, encapsulated within liposomes, with anti...") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
||
| Line 12: | Line 12: | ||
<references/> | <references/> | ||
| − | [[Category: | + | [[Category:Drugs]] |
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Liposomal chemotherapy]] | [[Category:Liposomal chemotherapy]] | ||
Revision as of 22:53, 13 June 2018
General information
Class/mechanism: A formulation of the citrate salt of the antineoplastic anthracycline antibiotic doxorubicin, encapsulated within liposomes, with antitumor activity.
Diseases for which it is used
Also known as
- Generic names: liposome-encapsulated doxorubicin citrate, NPLD
- Brand name: Myocet